Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho
Avant Technologies, Inc. Issues Retraction of September 24, 2025 Press Release
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
Doctors Are Being Outpaced by AI-Powered Algorithms -- Here's What It Means for Investors
Avant Technologies Creating New Company for Expansion of Diabetes Program
Avant Technologies and Partner, Ainnova, Finalizing Automated Retinal Camera Prototype Ahead of Full-Scale Development

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.